Mitigating Age-Related Ovarian Dysfunction with the Anti-Inflammatory Agent MIT-001

Int J Mol Sci. 2023 Oct 13;24(20):15158. doi: 10.3390/ijms242015158.

Abstract

Ovarian aging is a major obstacle in assisted reproductive medicine because it leads to ovarian dysfunction in women of advanced age. Currently, there are no effective treatments to cure age-related ovarian dysfunction. In this study, we investigated the effect of MIT-001 on the function of aged ovaries. Young and old mice were utilized in this study. MIT-001 was intraperitoneally administered, and the number of follicles and oocytes was analyzed. Each group was then retrieved for RNA and protein isolation. Total RNA was subjected to mRNA next-generation sequencing. Protein extracts from ovarian lysates were used to evaluate various cytokine levels in the ovaries. MIT-001 enhanced follicles and the number of oocytes were compared with non-treated old mice. MIT-001 downregulated immune response-related transcripts and cytokines in the ovaries of old mice. MIT-001 modulates the immune complex responsible for generating inflammatory signals and has the potential to restore the function of old ovaries and improve female fertility.

Keywords: RNA-seq; aging; cytokines; inflammation; ovarian dysfunction; ovarian restoration.

MeSH terms

  • Aged
  • Aging
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Cytokines / pharmacology
  • Female
  • Humans
  • Mice
  • Oocytes*
  • Ovarian Diseases*
  • RNA / pharmacology

Substances

  • Cytokines
  • Anti-Inflammatory Agents
  • RNA